You might want to take a look at Alignment Healthcare Inc (ALHC) now

With 2.23 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.92 million shares. The 52-week range on ALHC shows that it touched its highest point at $16.25 and its lowest point at $4.46 during that stretch. It currently has a 1-year price target of $17.05. Beta for the stock currently stands at 1.50.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ALHC was down-trending over the past week, with a drop of -3.22%, but this was down by -0.20% over a month. Three-month performance surged to 19.97% while six-month performance rose 52.64%. The stock gained 179.70% in the past year, while it has gained 33.51% so far this year. A look at the trailing 12-month EPS for ALHC yields -0.67 with Next year EPS estimates of -0.21. For the next quarter, that number is -0.13. This implies an EPS growth rate of 39.95% for this year and 48.03% for next year. EPS is expected to grow by 48.16% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -22.95%.

Float and Shares Shorts:

At present, 191.78 million ALHC shares are outstanding with a float of 105.90 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ALHC since 10 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.64264 being high and -$0.72298 being low. For ALHC, this leads to a yearly average estimate of -$0.68281. Based on analyst estimates, the high estimate for the next quarter is $0.03 and the low estimate is $0.0. The average estimate for the next quarter is thus $0.01.